Journal of Immunology Research / 2016 / Article / Tab 1

Research Article

Serum Levels of Soluble ST2 and IL-10 Are Associated with Disease Severity in Patients with IgA Nephropathy

Table 1

Demographic and clinical characteristics of participants.

HC ()IgAN patients ()
Stage I+II ()Stage III ()Stage IV+V ()

Age, year43 (18–76)37 (17–69)46 (19–72)42 (23–77)
Female/male15/1914/1216/138/11
Lymphocytes, 109/L1.72 (0.84–2.87)1.68 (0.87–3.22)2.04 (0.82–4.13)2.12 (0.89–3.92)
Serum albumin, g/L43.2 (40.8–50.6)35.3 (14.3–41.433.2 (8.84–39.630.24 (12.1–38.9
Serum uric acid, μmol/L305 (245–416)342 (231–604)371 (252–611)383 (247–584)
Triglycerides, mmol/L1.27 (0.51–1.78)2.32 (0.62–6.53)2.56 (0.58–4.78)2.23 (0.74–4.94)
Cholesterol, mmol/L4.07 (2.86–5.47)5.12 (3.12–8.78)6.24 (3.23–9.14)5.85 (2.86–10.05)
Urinary proteins, g/24 h0.048 (0–0.12)2.61 (0.65–4.133.46 (0.52–6.363.17 (0.71–5.89
Urea nitrogen, mmol/L5.14 (3.62–6.68)5.95 (2.65–13.1)6.46 (3.13–10.35)6.87 (4.02–12.8)
eGFR, mL/min/1.73 m2104.5 (88.5–112.4)89.4 (41.6–117.374.2 (45.1–113.860.7 (18.3–102.9
Microscopic hematuria, rbc/hpf1.1 (0–2.4)7.1 (0.2–23.47.8 (0.8–27.68.5 (1.2–19.4
Serum calcium, mmol/L2.38 (1.91–2.62)1.91 (1.48–2.351.82 (1.52–2.231.86 (1.56–2.43
Serum phosphorus, mmol/L1.15 (0.74–1.49)1.44 (0.84–1.911.58 (0.81–2.121.52 (0.93–2.04
Serum IgA, g/L1.87 (1.03–2.98)3.16 (1.78–4.853.34 (1.45–4.973.52 (1.39–4.79

Data shown are median and range, except specified. versus the HC.